Literature DB >> 9360990

Expression of heparin-binding epidermal growth factor-like growth factor during pancreas development. A potential role of PDX-1 in transcriptional activation.

H Kaneto1, J Miyagawa, Y Kajimoto, K Yamamoto, H Watada, Y Umayahara, T Hanafusa, Y Matsuzawa, Y Yamasaki, S Higashiyama, N Taniguchi.   

Abstract

The development of the pancreas appears to be regulated by various growth factors. We report here the expression of heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) in the developing pancreas. Immunostaining of fetal and neonatal rat pancreata, in which endocrine cells are visible as cell clusters often associated with primitive ducts or ductular cells, revealed that most of the cluster-forming cells and primitive ducts or ductular cells express HB-EGF protein. In contrast, the exocrine pancreas lacked HB-EGF expression. Based on findings that the expression pattern was similar to that of the homeodomain-containing transcription factor PDX-1 (IDX-1/STF-1/IPF1) and that the regulatory region of the HB-EGF gene contained sequences similar to the PDX-1-binding A element, we examined whether PDX-1 could be a potential activator of HB-EGF gene expression. The results of reporter gene analyses suggested that the HB-EGF gene promoter is PDX-1-responsive and that the activity of the promoter in pancreatic beta cell-derived betaTC1 cells depends on the PDX-1 binding site-like sequences. Gel-mobility shift analyses using an anti-PDX-1 antibody indicated that PDX-1 is a specific and dominant binding factor for an A element-like sequence in the HB-EGF gene. These observations suggest the possible involvement of HB-EGF in pancreas development. While PDX-1 is essential for pancreas development, HB-EGF may function as a mediator of PDX-1 and thus be involved in the development of the endocrine pancreas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360990     DOI: 10.1074/jbc.272.46.29137

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Identification of a portable repression domain and an E1A-responsive activation domain in Pax4: a possible role of Pax4 as a transcriptional repressor in the pancreas.

Authors:  Y Fujitani; Y Kajimoto; T Yasuda; T A Matsuoka; H Kaneto; Y Umayahara; N Fujita; H Watada; J I Miyazaki; Y Yamasaki; M Hori
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice.

Authors:  Lawrence Rosenberg; Mark Lipsett; Ji-Won Yoon; Marc Prentki; Rennian Wang; Hee-Sook Jun; Gary L Pittenger; David Taylor-Fishwick; Aaron I Vinik
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

3.  Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes.

Authors:  Hideaki Kaneto; Taka-Aki Matsuoka; Yoshihisa Nakatani; Dan Kawamori; Takeshi Miyatsuka; Munehide Matsuhisa; Yoshimitsu Yamasaki
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

4.  Involvement of oxidative stress and the JNK pathway in glucose toxicity.

Authors:  Hideaki Kaneto; Yoshihisa Nakatani; Dan Kawamori; Takeshi Miyatsuka; Taka-aki Matsuoka
Journal:  Rev Diabet Stud       Date:  2005-02-10

5.  Pleiotropic Roles of PDX-1 in the Pancreas.

Authors:  Hideaki Kaneto; Takeshi Miyatsuka; Dan Kawamori; Taka-Aki Matsuoka
Journal:  Rev Diabet Stud       Date:  2008-02-10

6.  Transmembrane and soluble isoforms of heparin-binding epidermal growth factor-like growth factor regulate distinct processes in the pancreas.

Authors:  Kevin C Ray; Stacy A Blaine; M Kay Washington; Ada H Braun; Amar B Singh; Raymond C Harris; Paul A Harding; Robert J Coffey; Anna L Means
Journal:  Gastroenterology       Date:  2009-08-16       Impact factor: 22.682

7.  The neurosurvival factor Humanin inhibits beta-cell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonobese diabetic mice.

Authors:  Phuong T Hoang; Patricia Park; Laura J Cobb; Valdislava Paharkova-Vatchkova; Michael Hakimi; Pinchas Cohen; Kuk-Wha Lee
Journal:  Metabolism       Date:  2009-10-01       Impact factor: 8.694

8.  Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma.

Authors:  Kohei Miyata; Fusanori Yotsumoto; Sung Ouk Nam; Takashi Odawara; Sadao Manabe; Toyokazu Ishikawa; Hiroaki Itamochi; Junzo Kigawa; Shuji Takada; Hiroshi Asahara; Masahide Kuroki; Shingo Miyamoto
Journal:  Cancer Med       Date:  2014-07-24       Impact factor: 4.452

Review 9.  Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesis.

Authors:  Fabrizio Vinante; Antonella Rigo
Journal:  Toxins (Basel)       Date:  2013-06       Impact factor: 4.546

Review 10.  Role of pancreatic transcription factors in maintenance of mature β-cell function.

Authors:  Hideaki Kaneto; Taka-aki Matsuoka
Journal:  Int J Mol Sci       Date:  2015-03-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.